15
Participants
Start Date
July 30, 2019
Primary Completion Date
July 5, 2022
Study Completion Date
July 5, 2022
Daprodustat
Daprodustat will be available as 1 milligram (mg), 2 mg and 4 mg tablets strengths. One tablet to be taken daily without regard for food.
rhEPO
rhEPO (epoetin alfa OR darbepoetin alfa) is commercially available in various single dose vials and single-dose prefilled syringes. It will be given as subcutaneous injection.
Ferrous sulfate containing the stable iron isotope (57Fe)
57Fe will be available in oral solution. An oral solution will be administered containing 10 mg of 57Fe as ferrous sulfate.
Ferrous sulfate containing the stable iron isotope (58Fe)
58Fe will be available in oral solution. An oral solution will be administered containing 3 mg of 58Fe as ferrous sulfate with 7 mg of 56Fe as ferrous sulfate (natural abundance Fe).
GSK Investigational Site, Lufkin
GSK Investigational Site, Fort Worth
GSK Investigational Site, San Antonio
Lead Sponsor
GlaxoSmithKline
INDUSTRY